Copyright
©The Author(s) 2017.
World J Gastroenterol. Apr 14, 2017; 23(14): 2511-2518
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2511
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2511
Figure 2 Berberine treatment induced cell cycle arrest in G2/M phase.
A: Flow cytometry analysis of proliferating KYSE-70 cells at 48 h after administration of 50 μmol/L berberine; B: Relative percentages of berberine-treated cells to control cells in different cell cycle phases are shown as the mean ± SE of three independent experiments. aP < 0.05 vs controls; C: Protein expression level of p21 in KYSE-70 cells was examined after berberine administration at 6, 12 and 24 h.
- Citation: Jiang SX, Qi B, Yao WJ, Gu CW, Wei XF, Zhao Y, Liu YZ, Zhao BS. Berberine displays antitumor activity in esophageal cancer cells in vitro. World J Gastroenterol 2017; 23(14): 2511-2518
- URL: https://www.wjgnet.com/1007-9327/full/v23/i14/2511.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i14.2511